Rosuvastatin Calcium Patent Expiration
Rosuvastatin Calcium was first introduced by Astrazeneca Uk Ltd
Rosuvastatin Calcium Patents
Given below is the list of patents protecting Rosuvastatin Calcium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ezallor Sprinkle | US10413543 | Stable multiparticulate pharmaceutical composition of rosuvastatin | Feb 12, 2036 | Sun Pharm |
| Crestor |
US6858618 (Pediatric) | Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
Jun 17, 2022
(Expired) | Astrazeneca |
| Crestor | US6858618 | Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
Dec 17, 2021
(Expired) | Astrazeneca |
| Crestor |
US6316460 (Pediatric) | Pharmaceutical compositions |
Feb 04, 2021
(Expired) | Astrazeneca |
| Crestor | US6316460 | Pharmaceutical compositions |
Aug 04, 2020
(Expired) | Astrazeneca |
| Crestor |
US7030152 (Pediatric) | Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
Oct 02, 2018
(Expired) | Astrazeneca |
| Crestor |
US7964614 (Pediatric) | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
Oct 02, 2018
(Expired) | Astrazeneca |
| Crestor | US7030152 | Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
Apr 02, 2018
(Expired) | Astrazeneca |
| Crestor | US7964614 | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
Apr 02, 2018
(Expired) | Astrazeneca |
| Crestor |
USRE37314 (Pediatric) | Pyrimidine derivatives |
Jul 08, 2016
(Expired) | Astrazeneca |
| Crestor | USRE37314 | Pyrimidine derivatives |
Jan 08, 2016
(Expired) | Astrazeneca |
Rosuvastatin Calcium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List